Skip to main content
. 2020 Apr 17;11:216. doi: 10.3389/fendo.2020.00216

Figure 4.

Figure 4

Relation of treatment-induced changes in plasma N-acetylaspartate (NAA) concentrations to the corresponding changes in HbA1c and fasting glucose levels at 1-year post-treatment.